James Vollins Biography and Net Worth

Insider of BioDelivery Sciences International

James Vollins has been our General Counsel, Chief Compliance Officer and Corporate Secretary, and member of the Executive Leadership Team since November 2018. Mr. Vollins has twenty-five years of legal experience with over ten years of in-house experience in the pharmaceutical industry, which includes work on several major strategic transactions and a successful initial public offering. From 2014 to 2018, Mr. Vollins was General Counsel, Chief Compliance Officer and Corporate Secretary for Bio Products Laboratory Limited, a UK based manufacturer of plasma-derived therapies, where he helped lead the transformation of the business from a government owned not-for-profit to a high-performing commercial enterprise that successfully launched three new drugs in the U.S., expanded its sales force, and achieved significant revenue growth. Mr. Vollins has also worked for other industry-leading pharmaceutical companies, including Grifols Inc., Talecris Biotherapeutics, Inc. and Pfizer Inc. Mr. Vollins received a Juris Doctor from Case Western Reserve University School of Law and a Bachelor of Arts from Wesleyan University.

What is James Vollins' net worth?: The estimated net worth of James Vollins is at least $21,426.47 as of February 8th, 2021. Mr. Vollins owns 3,833 shares of BioDelivery Sciences International stock worth more than $21,426 as of April 25th. This net worth approximation does not reflect any other investments that Mr. Vollins may own. Additionally, Mr. Vollins receives a salary of $586,680.00 as Insider at BioDelivery Sciences International. Learn More about James Vollins' net worth.
How old is James Vollins?: Mr. Vollins is currently 53 years old. There are 4 older executives and no younger executives at BioDelivery Sciences International. The oldest executive at BioDelivery Sciences International is Dr. Thomas B. Smith FAAFP, M.D., Chief Medical Officer, who is 61 years old. Learn More on James Vollins' age.
What is James Vollins' salary?: As the Insider of BioDelivery Sciences International, Inc., Mr. Vollins earns $586,680.00 per year. There are 2 executives that earn more than Mr. Vollins. The highest earning executive at BioDelivery Sciences International is Mr. Scott M. Plesha, Pres & Chief Commercial Officer, who commands a salary of $629,460.00 per year. Learn More on James Vollins' salary.
How do I contact James Vollins?: The corporate mailing address for Mr. Vollins and other BioDelivery Sciences International executives is 4131 PARKLAKE AVENUE SUITE 225, RALEIGH NC, 27612. BioDelivery Sciences International can also be reached via phone at (919) 582-9050 and via email at [email protected]. Learn More on James Vollins' contact information.
Has James Vollins been buying or selling shares of BioDelivery Sciences International?: James Vollins has not been actively trading shares of BioDelivery Sciences International within the last three months. Most recently, James Vollins sold 18,541 shares of the business's stock in a transaction on Friday, February 4th. The shares were sold at an average price of $3.60, for a transaction totalling $66,747.60. Learn More on James Vollins' trading history.
Who are BioDelivery Sciences International's active insiders?: BioDelivery Sciences International's insider roster includes John Golubieski (CFO & Chief Accounting Officer ), Kevin Kotler (Director), Mark Sirgo (Director), and James Vollins (Insider). Learn More on BioDelivery Sciences International's active insiders.

James Vollins Insider Trading History at BioDelivery Sciences International

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/4/2022	Sell	18,541	$3.60	$66,747.60
2/8/2021	Sell	3,833	$4.16	$15,945.28	3,833
2/4/2021	Sell	8,303	$3.97	$32,962.91	3,833
12/16/2020	Sell	9,505	$4.48	$42,582.40	20,320
12/14/2020	Sell	20,320	$4.46	$90,627.20	20,320
5/21/2020	Sell	21,666	$4.60	$99,663.60	21,666
3/16/2020	Sell	3,833	$3.50	$13,415.50
11/15/2019	Sell	29,825	$6.21	$185,213.25

James Vollins Buying and Selling Activity at BioDelivery Sciences International

BioDelivery Sciences International Company Overview

BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; and Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. The company also provides ELYXYB, a celecoxib oral solution for the treatment of migraine with or without aura in adults; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in cancer patients. BioDelivery Sciences International, Inc. was incorporated in 1997 and is headquartered in Raleigh, North Carolina. As of March 18, 2022, BioDelivery Sciences International, Inc. operates as a subsidiary of Collegium Pharmaceutical, Inc.

Today's Range

Now: $5.59

$5.59

$5.60

50 Day Range

MA: $5.58

$5.54

$5.60

2 Week Range

Now: $5.59

$2.50

$5.62

Volume

2,090,567 shs

Average Volume

3,340,554 shs

Market Capitalization

$577.05 million

P/E Ratio

6.74

Dividend Yield

N/A

Beta

0.56

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>

James Vollins Biography and Net Worth

What is James Vollins' net worth?

How old is James Vollins?

What is James Vollins' salary?

How do I contact James Vollins?

Has James Vollins been buying or selling shares of BioDelivery Sciences International?

Who are BioDelivery Sciences International's active insiders?